<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Int J Surg</journal-id><journal-id journal-id-type="iso-abbrev">Int J Surg</journal-id><journal-id journal-id-type="pmc-domain-id">2035</journal-id><journal-id journal-id-type="pmc-domain">lwwopen</journal-id><journal-id journal-id-type="publisher-id">JS9</journal-id><journal-title-group><journal-title>International Journal of Surgery (London, England)</journal-title></journal-title-group><issn pub-type="ppub">1743-9191</issn><issn pub-type="epub">1743-9159</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>Lippincott Open Access</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC12430870</article-id><article-id pub-id-type="pmcid-ver">PMC12430870.1</article-id><article-id pub-id-type="pmcaid">12430870</article-id><article-id pub-id-type="pmcaiid">12430870</article-id><article-id pub-id-type="pmid">40503788</article-id><article-id pub-id-type="doi">10.1097/JS9.0000000000002750</article-id><article-id pub-id-type="publisher-id">IJS-D-25-01390</article-id><article-version-alternatives><article-version article-version-type="pmc-version">1</article-version><article-version vocab="JAV" vocab-identifier="http://www.niso.org/publications/rp/RP-8-2008.pdf" article-version-type="Version of Record">3</article-version></article-version-alternatives><article-categories><subj-group subj-group-type="heading"><subject>Research Letter</subject></subj-group></article-categories><title-group><article-title>Prognostic value of iron-metabolism biomarkers in critically ill patients with atrial fibrillation: a machine learning-based retrospective cohort study</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Huang</surname><given-names initials="C">Chaoqun</given-names></name><degrees>MD</degrees><email>2234068064@qq.com</email><xref rid="aff1" ref-type="aff">
<sup>a</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Shu</surname><given-names initials="S">Shangzhi</given-names></name><degrees>MD</degrees><email>shusz22@mails.jlu.edu.cn</email><xref rid="aff1" ref-type="aff">
<sup>a</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Hui</surname><given-names initials="X">Xuejun</given-names></name><degrees>MD</degrees><email>738320979@qq.com</email><xref rid="aff2" ref-type="aff">
<sup>b</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Narisawa</surname><given-names initials="M">Megumi</given-names></name><degrees>MD</degrees><email>m.narisawa2016@gmail.com</email><xref rid="aff3" ref-type="aff">
<sup>c</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Jin</surname><given-names initials="X">Xiongjie</given-names></name><degrees>MD, PhD</degrees><email>15526782806@163.com</email><xref rid="aff4" ref-type="aff">
<sup>d</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Li</surname><given-names initials="S">Shuyan</given-names></name><degrees>MD, PhD</degrees><xref rid="aff1" ref-type="aff">
<sup>a</sup>
</xref><xref rid="COR0001" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Cheng</surname><given-names initials="XW">Xian Wu</given-names></name><degrees>MD, PhD, FAHA</degrees><email>chengxw0908@163.com</email><xref rid="aff3" ref-type="aff">
<sup>c</sup>
</xref><xref rid="aff4" ref-type="aff">
<sup>d</sup>
</xref><xref rid="COR0001" ref-type="corresp">*</xref></contrib><aff id="aff1"><label>a</label>Department of Cardiology, the First Hospital of Jilin University, Changchun, China</aff><aff id="aff2"><label>b</label>Department of Nephrology, the Second Hospital of Jilin University, Changchun, China</aff><aff id="aff3"><label>c</label>Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Japan</aff><aff id="aff4"><label>d</label>Department of Cardiology and Hypertension, Jilin Provincial Key Laboratory of Stress and Cardiovascular Disease, Yanbian University Hospital, Yanji, China</aff></contrib-group><author-notes><corresp id="COR0001"><label>*</label>Corresponding authors. Address: Department of Cardiology, First Hospital of Jilin University, No. 71 Xinmin Street, Changchun, Jilin 130021, China. Tel.: +86 15104302232. E-mail: <email>li_sy@jlu.edu.cn</email> (S. Li); Department of Cardiology and Hypertension, Yanbian University Hospital, 1327 Juzijie, Yanji, Jilin 133000, China. Tel.: +86 15526770371. E-mail: <email>chengxw0908@163.com</email> (X. Cheng).</corresp></author-notes><pub-date pub-type="collection"><month>9</month><year>2025</year></pub-date><pub-date pub-type="epub"><day>12</day><month>6</month><year>2025</year></pub-date><volume>111</volume><issue>9</issue><issue-id pub-id-type="pmc-issue-id">496813</issue-id><fpage>6486</fpage><lpage>6490</lpage><history><date date-type="received"><day>17</day><month>3</month><year>2025</year></date><date date-type="accepted"><day>02</day><month>6</month><year>2025</year></date></history><pub-history><event event-type="pmc-release"><date><day>12</day><month>09</month><year>2025</year></date></event><event event-type="pmc-live"><date><day>13</day><month>09</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-09-13 11:25:14.803"><day>13</day><month>09</month><year>2025</year></date></event></pub-history><permissions><copyright-statement>Copyright &#169; 2025 The Author(s). Published by Wolters Kluwer Health, Inc.</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbysalicense">https://creativecommons.org/licenses/by-sa/4.0/</ali:license_ref><license-p>This is an open access article distributed under the <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-sa/4.0/">Creative Commons Attribution-ShareAlike License 4.0</ext-link>, which allows others to remix, tweak, and build upon the work, even for commercial purposes, as long as the author is credited and the new creations are licensed under the identical terms.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="js9-111-6486.pdf"/><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="js9-111-6486.pdf"/><abstract><p>Iron homeostasis may significantly impact outcomes in critically ill patients with atrial fibrillation (AF), yet its prognostic value remains unclear. Analyzing 2145 AF patients from MIMIC-IV database, we found 43% mortality (n&#160;=&#160;928) at 1-year follow-up. Elevated ferritin (Q4 HR 1.59, 95%CI 1.30&#8211;1.95, <italic toggle="yes">P</italic> &lt; 0.001) and serum iron (Q4 HR 1.33, 95%CI 1.11&#8211;1.60, <italic toggle="yes">P</italic> =&#160;0.002) predicted higher mortality, while higher transferrin (Q4: HR 0.65, 95%CI: 0.53&#8211;0.79, <italic toggle="yes">P</italic> &lt; 0.001) and TIBC (Q4: HR 0.64, 95%CI: 0.53&#8211;0.79, <italic toggle="yes">P</italic> &lt; 0.001) were protective. The gradient boosting decision trees model achieved excellent prediction (AUC 0.85 training/validation, 0.71 testing), with TIBC as the top predictor. These iron-metabolism indicators provide strong prognostic value for risk stratification in critically ill patients with AF.</p></abstract><kwd-group><kwd>atrial fibrillation</kwd><kwd>critically ill patients</kwd><kwd>iron metabolism</kwd><kwd>machine learning</kwd><kwd>mortality prediction</kwd><kwd>prognosis</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>SDC</meta-name><meta-value>T</meta-value></custom-meta><custom-meta><meta-name>OPEN-ACCESS</meta-name><meta-value>TRUE</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro"><title>Introduction</title><p>Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia. The occurrence of AF in critically ill patients is associated with significantly elevated risks of morbidity and mortality<sup>[</sup><xref rid="R1" ref-type="bibr">1</xref><sup>]</sup>, underscoring the need for effective AF management and accurate risk stratification.</p><p>Iron metabolism plays a pivotal role in cardiovascular health and disease<sup>[</sup><xref rid="R2" ref-type="bibr">2</xref><sup>]</sup>. High ferritin and iron intake were associated with an increased risk of AF<sup>[</sup><xref rid="R3" ref-type="bibr">3</xref>,<xref rid="R4" ref-type="bibr">4</xref><sup>]</sup>. However, the prognostic value of iron makers in critically ill patients with AF remains poorly understood. The goals of this study were to clarify iron metabolism&#8217;s prognostic role in critically ill patients with AF and develop a machine learning-enhanced risk stratification tool to identify high-risk subgroups. This cohort study has been reported in line with the STROCSS guidelines<sup>[</sup><xref rid="R5" ref-type="bibr">5</xref><sup>]</sup>.<boxed-text id="UBT0001" position="float" orientation="portrait"><sec><title>HIGHLIGHTS</title><p>
<list list-type="bullet"><list-item><p>Iron homeostasis (particularly TIBC) independently predicts mortality in critically ill patients with AF.</p></list-item><list-item><p>Machine learning integration of iron markers achieves superior prediction (AUC 0.85) versus conventional scores.</p></list-item><list-item><p>Dual-directional effects: Ferritin (&#8593;risk) and TIBC/transferrin (&#8595;risk) provide complementary prognostic value.</p></list-item></list></p></sec></boxed-text></p></sec><sec><title>Methodology</title><p>This single-center retrospective cohort study drew its data from the MIMIC-IV. AF was identified using ICD-9 code (427.31) and ICD-10 codes (I48.91, I48.0, I48.2, I48.19, I48.20, I48.1, I48.21, and I48.11). The prognostic values of the iron-metabolism indicators (ferritin, serum iron, transferrin, and total iron-binding capacity [TIBC]) were analyzed by quartiles using Kaplan-Meier, multivariable Cox regression, and a restricted cubic spline (RCS) analysis. For mortality prediction, feature selection combined LASSO regression and Boruta algorithm to identify key predictors. Machine learning (ML) models were developed, with performance assessed by AUC, calibration curves, and decision curve analysis. The optimal model was interpreted via SHAP values to evaluate feature importance. Continuous variables are presented as mean&#160;&#177; SD or median[IQR], categorical variables as n(%), analyzed using appropriate statistical tests (t-test/Mann-Whitney U-test or &#967;<sup>2</sup>-test) with significance at <italic toggle="yes">P</italic> &lt;0.05. The study protocol was registered in the Research Registry (UIN: researchregistry11251; available at: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.researchregistry.com/browse-the-registry#home/" ext-link-type="uri">https://www.researchregistry.com/browse-the-registry#home/</ext-link>). The study flowchart is shown in Fig. 1. Methodological details are provided in the Supplemental Digital Content.</p></sec><sec sec-type="results"><title>Results</title><p>This study included 2145 critically ill patients with AF. The patients were divided into survival and death groups based on their 1-year outcomes after ICU admission, with 928 (43%) patients succumbing. Baseline characteristics are summarized in Table S1 (available at: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://links.lww.com/JS9/E397" ext-link-type="uri">http://links.lww.com/JS9/E397</ext-link>). Notably, the death group exhibited significantly higher ferritin levels (<italic toggle="yes">P</italic> &lt; 0.001) and lower transferrin/TIBC levels (both <italic toggle="yes">P</italic> &lt; 0.001), while serum iron showed no intergroup difference.</p><sec><title>The prognostic values of the iron-metabolism indicators</title><p>Quartile stratifications of iron-metabolism indicators were established (Table S2, available at: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://links.lww.com/JS9/E397" ext-link-type="uri">http://links.lww.com/JS9/E397</ext-link>), with these thresholds used for subsequent analyses. Kaplan-Meier analysis demonstrated significantly worse survival for patients with elevated ferritin and reduced transferrin/TIBC levels (all log-rank <italic toggle="yes">P</italic> &lt; 0.001), while serum iron exhibited a U-shaped mortality relationship (Fig. <xref rid="F2" ref-type="fig">2</xref>A). Then, multivariable Cox models (fully adjusted) confirmed iron-mortality associations: ferritin (Q4: Q4: HR 1.59, 95%CI: 1.30&#8211;1.95, <italic toggle="yes">P</italic> &lt; 0.001) and serum iron (Q4: HR 1.33, 95%CI: 1.11&#8211;1.60, <italic toggle="yes">P</italic> =&#160;0.002) predicted increased risk, while transferrin (Q3: HR 0.72, 95%CI: 0.60&#8211;0.87, <italic toggle="yes">P</italic> &lt; 0.001; Q4: HR 0.65, 95%CI: 0.53&#8211;0.79, <italic toggle="yes">P</italic> &lt; 0.001) and TIBC (Q3: HR 0.72, 95%CI: 0.60&#8211;0.86, <italic toggle="yes">P</italic> &lt; 0.001; Q4: HR 0.64, 95%CI: 0.53&#8211;0.79, <italic toggle="yes">P</italic> &lt; 0.001) showed protection (Fig. <xref rid="F2" ref-type="fig">2</xref>B and Table S3, available at: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://links.lww.com/JS9/E397" ext-link-type="uri">http://links.lww.com/JS9/E397</ext-link>).<fig position="float" id="F1" orientation="portrait"><label>Figure 1.</label><caption><p>Patient screening flow from the MIMIC-IV database.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="js9-111-6486-g001.jpg"/></fig>
<fig position="float" id="F2" orientation="portrait"><label>Figure 2.</label><caption><p>The prognostic values of the iron-metabolism indicators. (A) The relationship between the iron-metabolism indicators at different levels and all-cause mortality, analyzed using Kaplan-Meier curves. (B) The Cox proportional hazard ratios for the iron-metabolism indicators. Adjusted for RBC, HGB, RDW, HCT, NLR, SOFA score, gender, age, hypertension, diabetes, heart failure, myocardial infarction, sepsis, AKI. (C) The restricted cubic spline (RCS) analysis of iron-metabolism indicators with all-cause mortality. Adjusted for RBC, HGB, RDW and HCT. AKI: acute kidney injury, HCT: hematocrit, HGB: hemoglobin, NLR: neutrophil-to-lymphocyte ratio; RBC: red blood cells, RDW: red blood cell distribution width, SOFA: sequential organ failure assessment; TIBC: total iron-binding capacity.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="js9-111-6486-g002.jpg"/></fig>
</p><p>RCS analyses revealed distinct iron-mortality associations: ferritin was negatively associated, serum iron exhibited a U-shaped relationship, and transferrin and TIBC showed positive associations (Fig. <xref rid="F2" ref-type="fig">2</xref>C). Serum iron levels below the median (38&#160;&#181;g/dL) were associated with an improved prognosis (HR per SD 0.53, 95%CI: 0.34&#8211;0.82, <italic toggle="yes">P</italic> =&#160;0.013), whereas levels above the median were linked to adverse outcomes (HR per SD 1.11, 95%CI: 1.03&#8211;1.19, <italic toggle="yes">P</italic> =&#160;0.001).</p><p>To validate robustness, we dichotomized iron-metabolism indicators at median values and performed stratified analyses. The results showed higher ferritin and lower transferrin/TIBC levels were consistently associated with increased long-term mortality across all subgroups (Figure S1, available at: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://links.lww.com/JS9/E396" ext-link-type="uri">http://links.lww.com/JS9/E396</ext-link>).</p><p>In addition, higher ferritin and lower transferrin/TIBC levels were associated with longer hospital and ICU stays (all <italic toggle="yes">P</italic> &lt; 0.001), whereas serum iron levels showed no significant association (Figure S2, available at: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://links.lww.com/JS9/E396" ext-link-type="uri">http://links.lww.com/JS9/E396</ext-link>).</p></sec><sec><title>The prediction model of 1-year all-cause mortality</title><p>Feature selection via LASSO and Boruta algorithms initially identified 18 potential predictors, which were refined to 16 after excluding transferrin and neutrophils due to high collinearity (TIBC-transferrin: r =&#160;1.0; WBC-neutrophils: r =&#160;0.79; both <italic toggle="yes">P</italic> &lt; 0.001) (Table S4, available at: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://links.lww.com/JS9/E397" ext-link-type="uri">http://links.lww.com/JS9/E397</ext-link>and Figure S3, available at: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://links.lww.com/JS9/E396" ext-link-type="uri">http://links.lww.com/JS9/E396</ext-link>).</p><p>Through comprehensive evaluation of nine ML models using 10-fold cross-validation (Fig. <xref rid="F3" ref-type="fig">3</xref>A and Figure S4, available at: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://links.lww.com/JS9/E396" ext-link-type="uri">http://links.lww.com/JS9/E396</ext-link>), gradient boosting decision trees (GBDT) demonstrated optimal validation performance (AUC 0.85) with superior stability compared to eXtreme gradient boosting (suggesting potential overfitting), and was therefore selected as the final model. Notably, GBDT significantly outperformed conventional prognostic scores (SOFA score and Charlson index).<fig position="float" id="F3" orientation="portrait"><label>Figure 3.</label><caption><p>Multi-model comparison and optimal model evaluation. (A) The predictive performance of multiple machine learning models for 1-year mortality prediction. (B) The diagnostic performance of the optimal GBDT model. (C) Feature attributions in SHAP analysis of the optimal GBDT model, where each line represents a feature, with SHAP values plotted on the x-axis. Red dots: higher values, blue dots: lower values. (D) Variable importance in SHAP analysis of the optimal GBDT model shown as bars, illustrating their contribution to the model predictions. (E) SHAP scores highlighting the predicted risk of 1-year all-cause mortality for an individual subject. ABL: Serum albumin, AKI: acute kidney injury, BUN: blood urea nitrogen, CRRT: continuous renal replacement therapy, GBDT: gradient boosting decision trees, GNB: Gaussian na&#239;ve Bayes, MLP: multilayer perceptron, NPV: negative predictive value, PPV: positive predictive value, pCO2: partial pressure of carbon dioxide, RDW: red cell distribution width, RBC: red blood cells, SBP: systolic blood pressure, SOFA: sequential organ failure assessment, TIBC: total iron-binding capacity, WBC: white blood cells.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="js9-111-6486-g003.jpg"/></fig>
</p><p>The final GBDT model, developed with 5-fold nested cross-validation (30% test set allocation), demonstrated strong discrimination: training AUC 0.85 (95%CI 0.83&#8211;0.87), validation AUC 0.83 (95%CI 0.80&#8211;0.89), and test AUC 0.71 (95%CI 0.67&#8211;0.75) (Fig. <xref rid="F3" ref-type="fig">3</xref>B and Figure S5, available at: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://links.lww.com/JS9/E396" ext-link-type="uri">http://links.lww.com/JS9/E396</ext-link>). The SHAP analysis elucidated the contribution of each variable in the GBDT model. Each feature&#8217;s contribution is shown by colored dots, with red denoting high-risk values and blue representing low-risk values (Fig. <xref rid="F3" ref-type="fig">3</xref>C). Figure 3D ranks their relative importance in the predictive model, with age, RDW, and pCO<sub>2</sub> emerged as the factors with the greatest influence on prognosis. TIBC followed closely behind, while serum iron and ferritin were of moderate significance, highlighting the pivotal role of iron-metabolism indicators in predicting long-term mortality. The representative case of critically ill patients with AF is provided in Fig. 3E to demonstrate the interpretability of the model: the patient achieved a low SHAP prediction score (0.36) and survived at 1 year following ICU admission.</p></sec></sec><sec sec-type="discussion"><title>Discussion</title><p>Iron is a vital mineral in the human body, playing a key role in numerous physiological processes, such as oxygen transport and storage, enzyme activity, and mitochondrial function<sup>[</sup><xref rid="R2" ref-type="bibr">2</xref><sup>]</sup>. Several studies have shown that even in the absence of anemia, iron directly affects non-hematopoietic tissues that are essential for physical performance, such as skeletal muscle and the myocardium<sup>[</sup><xref rid="R6" ref-type="bibr">6</xref>,<xref rid="R7" ref-type="bibr">7</xref><sup>]</sup>. However, when transferrin becomes highly saturated, excess iron binds to low-molecular-weight compounds, forming non-transferrin-bound iron (which is readily absorbed by hepatocytes and cardiomyocytes), potentially causing oxidant-mediated damage and leading to tissue injury and disease<sup>[</sup><xref rid="R8" ref-type="bibr">8</xref>,<xref rid="R9" ref-type="bibr">9</xref><sup>]</sup>. Consequently, iron dysregulation, including both iron deficiency and iron overload, is associated with the development of numerous diseases.</p><p>Iron homeostasis also plays a critical role in cardiac arrhythmias. Studies of both mice and humans have demonstrated that chronic iron overload is implicated in cardiac conduction block and AF<sup>[</sup><xref rid="R2" ref-type="bibr">2</xref><sup>]</sup>. The underlying mechanism may involve iron displacing calcium from its intracellular binding sites, thereby preventing the inactivation of calcium-dependent channels and prolonging the calcium influx<sup>[</sup><xref rid="R10" ref-type="bibr">10</xref><sup>]</sup>. This disruption of cardiac conduction can lead to the development of arrhythmias.</p><p>The present study revealed that elevated ferritin and serum iron significantly increased mortality risk in critically ill patients with AF, likely reflecting iron overload-induced oxidative stress and inflammation. In contrast, elevated transferrin and TIBC levels conferred protection, possibly by binding free iron, indicating efficient iron utilization and adequate iron reserves.</p><p>In summary, our findings further demonstrate the prognostic impact of disrupted iron metabolism on critically ill patients with AF, and they strongly support the use of iron-metabolism indicators as clinical prognostic markers. However, several limitations should be considered: (1) the single-center design limited our sample size; (2) potential unmeasured confounders (e.g., undocumented comorbidities or treatments) may persist; and (3) the causal relationship between iron dysregulation and outcomes remains unclear &#8211; whether iron supplementation or absorption inhibition improves prognosis requires further investigation.</p></sec><sec sec-type="conclusions"><title>Conclusion</title><p>Iron-metabolism indicators, particularly TIBC, were demonstrated to be significant prognostic factors in critically ill patients with AF, providing valuable insights into their complex interplay with AF. The machine learning-based prediction model developed herein and incorporating these indicators provides a promising tool for improving the prognostic assessment and for guiding the clinical management in this vulnerable population.</p></sec></body><back><ack><title>Acknowledgements</title><p>The authors would like to thank the Massachusetts Institute of Technology (MIT) for providing access to the publicly available MIMIC-IV database.</p></ack><fn-group><fn fn-type="other"><p>Supplemental Digital Content is available for this article. Direct URL citations are provided in the HTML and PDF versions of this article on the journal's website, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="www.lww.com/international-journal-of-surgery" ext-link-type="uri">www.lww.com/international-journal-of-surgery</ext-link>.</p></fn><fn fn-type="equal"><p>Published online 12 June 2025</p></fn></fn-group><sec><title>Ethical approval</title><p>This study used the publicly available MIMIC-IV database. All data were de-identified to comply with the Health Insurance Portability and Accountability Act (HIPAA) Privacy Rule, and no direct patient identifiers were accessible. Additionally, this study was reviewed and approved by the ethics committee of Yanbian University Hospital (approval no. 2025005).</p></sec><sec><title>Consent</title><p>None.</p></sec><sec><title>Sources of funding</title><p>This work was supported in part by grants from the National Natural Science Foundation of China (Nos. 81770485, 82370424 to X.W.C. and 82070524 to S.Y.L.). The study sponsors had no such involvement.</p></sec><sec><title>Author contributions</title><p>C.H.: conceptualization, formal analysis, investigation, methodology, writing &#8211; original draft; S.S., X.H., M.N., and X.J.: data curation, validation; S.L.: validation, writing &#8211; review &amp; editing; X.W.C.: conceptualization, funding acquisition, project administration, supervision, writing &#8211; review &amp; editing.</p></sec><sec sec-type="COI-statement"><title>Conflicts of interest disclosure</title><p>The authors declare no competing interests.</p></sec><sec><title>Research registration unique identifying number (UIN)</title><p>UIN: researchregistry11251; available at: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.researchregistry.com/browse-the-registry#home/" ext-link-type="uri">https://www.researchregistry.com/browse-the-registry#home/</ext-link>.</p></sec><sec><title>Guarantor</title><p>Xianwu Cheng.</p></sec><sec><title>Provenance and peer review</title><p>Not commissioned, externally peer-reviewed.</p></sec><sec sec-type="data-availability"><title>Data availability statement</title><p>The datasets provided in this study can be obtained from the MIMIC-IV official website (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://physionet.org/content/mimiciv/1.0/" ext-link-type="uri">https://physionet.org/content/mimiciv/1.0/</ext-link>).</p></sec><ref-list><title>References</title><ref id="R1"><label>[1]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wetterslev</surname><given-names>M</given-names></name><name name-style="western"><surname>Hylander</surname><given-names>MM</given-names></name><name name-style="western"><surname>Granholm</surname><given-names>A</given-names></name><etal/></person-group>. <article-title>Atrial fibrillation (AFIB) in the ICU: incidence, risk factors, and outcomes: the International AFIB-ICU Cohort Study</article-title>. <source>Crit Care Med</source><year>2023</year>;<volume>51</volume>:<fpage>1124</fpage>&#8211;<lpage>37</lpage>.<pub-id pub-id-type="pmid">37078722</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/CCM.0000000000005883</pub-id></mixed-citation></ref><ref id="R2"><label>[2]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sawicki</surname><given-names>KT</given-names></name><name name-style="western"><surname>De Jesus</surname><given-names>A</given-names></name><name name-style="western"><surname>Ardehali</surname><given-names>H</given-names></name></person-group>. <article-title>Iron metabolism in cardiovascular disease: physiology, mechanisms, and therapeutic targets</article-title>. <source>Circ Res</source><year>2023</year>;<volume>132</volume>:<fpage>379</fpage>&#8211;<lpage>96</lpage>.<pub-id pub-id-type="pmid">36730380</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1161/CIRCRESAHA.122.321667</pub-id><pub-id pub-id-type="pmcid">PMC9907000</pub-id></mixed-citation></ref><ref id="R3"><label>[3]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Habudele</surname><given-names>Z</given-names></name><name name-style="western"><surname>Chen</surname><given-names>G</given-names></name><name name-style="western"><surname>Qian</surname><given-names>SE</given-names></name><name name-style="western"><surname>Vaughn</surname><given-names>MG</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>J</given-names></name><name name-style="western"><surname>Lin</surname><given-names>H</given-names></name></person-group>. <article-title>High dietary intake of iron might be harmful to atrial fibrillation and modified by genetic diversity: a prospective cohort study</article-title>. <source>Nutrients</source><year>2024</year>;<volume>16</volume>:<fpage>593</fpage>.<pub-id pub-id-type="pmid">38474722</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/nu16050593</pub-id><pub-id pub-id-type="pmcid">PMC10935150</pub-id></mixed-citation></ref><ref id="R4"><label>[4]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Altieri</surname><given-names>C</given-names></name><name name-style="western"><surname>Pisano</surname><given-names>C</given-names></name><name name-style="western"><surname>Vincenzo</surname><given-names>L</given-names></name><etal/></person-group>. <article-title>Circulating levels of ferritin, RDW, PTLs as predictive biomarkers of postoperative atrial fibrillation risk after cardiac surgery in extracorporeal circulation</article-title>. <source>Int J Mol Sci</source><year>2022</year>;<volume>23</volume>:<fpage>14800</fpage>.<pub-id pub-id-type="pmid">36499124</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/ijms232314800</pub-id><pub-id pub-id-type="pmcid">PMC9741292</pub-id></mixed-citation></ref><ref id="R5"><label>[5]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Agha</surname><given-names>RA</given-names></name><name name-style="western"><surname>Mathew</surname><given-names>G</given-names></name><name name-style="western"><surname>Rashid</surname><given-names>R</given-names></name><etal/></person-group>. <article-title>Revised strengthening the reporting of cohort, cross-sectional and case-control studies in surgery (STROCSS) guideline: an update for the age of artificial intelligence</article-title>. <source>Premier J Sci</source><year>2025</year>;<volume>10</volume>:<fpage>100081</fpage>.</mixed-citation></ref><ref id="R6"><label>[6]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Charles-Edwards</surname><given-names>G</given-names></name><name name-style="western"><surname>Amaral</surname><given-names>N</given-names></name><name name-style="western"><surname>Sleigh</surname><given-names>A</given-names></name><etal/></person-group>. <article-title>Effect of iron isomaltoside on skeletal muscle energetics in patients with chronic heart failure and iron deficiency</article-title>. <source>Circulation</source><year>2019</year>;<volume>139</volume>:<fpage>2386</fpage>&#8211;<lpage>2398</lpage>.<pub-id pub-id-type="pmid">30776909</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1161/CIRCULATIONAHA.118.038516</pub-id></mixed-citation></ref><ref id="R7"><label>[7]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dziegala</surname><given-names>M</given-names></name><name name-style="western"><surname>Josiak</surname><given-names>K</given-names></name><name name-style="western"><surname>Kasztura</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>Iron deficiency as energetic insult to skeletal muscle in chronic diseases</article-title>. <source>J Cachexia, Sarcopenia Muscle</source><year>2018</year>;<volume>9</volume>:<fpage>802</fpage>&#8211;<lpage>15</lpage>.<pub-id pub-id-type="pmid">30178922</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/jcsm.12314</pub-id><pub-id pub-id-type="pmcid">PMC6204587</pub-id></mixed-citation></ref><ref id="R8"><label>[8]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kawabata</surname><given-names>T</given-names></name></person-group>. <article-title>Iron-induced oxidative stress in human diseases</article-title>. <source>Cells</source><year>2022</year>;<volume>11</volume>:<fpage>2152</fpage>.<pub-id pub-id-type="pmid">35883594</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/cells11142152</pub-id><pub-id pub-id-type="pmcid">PMC9324531</pub-id></mixed-citation></ref><ref id="R9"><label>[9]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ru</surname><given-names>Q</given-names></name><name name-style="western"><surname>Li</surname><given-names>Y</given-names></name><name name-style="western"><surname>Chen</surname><given-names>L</given-names></name><name name-style="western"><surname>Wu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Min</surname><given-names>J</given-names></name><name name-style="western"><surname>Wang</surname><given-names>F</given-names></name></person-group>. <article-title>Iron homeostasis and ferroptosis in human diseases: mechanisms and therapeutic prospects</article-title>. <source>Signal Transduct Target Ther</source><year>2024</year>:<volume>9</volume>:<fpage>271</fpage>.<pub-id pub-id-type="pmid">39396974</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41392-024-01969-z</pub-id><pub-id pub-id-type="pmcid">PMC11486532</pub-id></mixed-citation></ref><ref id="R10"><label>[10]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rose</surname><given-names>RA</given-names></name><name name-style="western"><surname>Sellan</surname><given-names>M</given-names></name><name name-style="western"><surname>JA</surname><given-names>S</given-names></name><etal/></person-group>. <article-title>Iron overload decreases CaV1.3-dependent L-type Ca2+ currents leading to bradycardia, altered electrical conduction, and atrial fibrillation</article-title>. <source>Circ Arrhythm Electrophysiol</source><year>2011</year>;<volume>4</volume>:<fpage>733</fpage>&#8211;<lpage>42</lpage>.<pub-id pub-id-type="pmid">21747058</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1161/CIRCEP.110.960401</pub-id><pub-id pub-id-type="pmcid">PMC3401539</pub-id></mixed-citation></ref></ref-list></back></article></pmc-articleset>